Neurizon Therapeutics Limited (ASX:NUZ)
Australia · Delayed Price · Currency is AUD 0.0750
-0.0040 (-5.06%)
Mar 31, 2026, 3:44 PM AEST
Neurizon Therapeutics Market Cap
Neurizon Therapeutics has a market cap or net worth of 53.11 million as of March 31, 2026. Its market cap has decreased by -6.19% in one year.
Market Cap
53.11M
Enterprise Value
46.78M
Revenue
5.98M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.08
Market Cap Chart
Since September 12, 2002, Neurizon Therapeutics's market cap has increased from 4.18M to 53.11M, an increase of 1,169.59%. That is a compound annual growth rate of 11.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 55.94M | 22.84% |
| Dec 31, 2025 | 45.54M | -45.58% |
| Dec 31, 2024 | 83.69M | 94.55% |
| Dec 29, 2023 | 43.02M | 112.09% |
| Dec 30, 2022 | 20.28M | -36.00% |
| Dec 31, 2021 | 31.69M | -4.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alterity Therapeutics | 87.00M |
| Arovella Therapeutics | 84.50M |
| LTR Pharma | 72.71M |
| Cynata Therapeutics | 71.24M |
| Radiopharm Theranostics | 70.88M |
| Immutep | 70.74M |
| Prescient Therapeutics | 55.73M |
| Imugene | 51.77M |